Effect of indomethacin on amniotic fluid prostaglandin and aldosterone levels in a fetus with Bartter syndrome.
H
H
Amsalem
D V
DV
Valsky
S
S
Yagel
D Hochner
DH
Celnikier
E Y
EY
Anteby
D000328:Adult; D000450:Aldosterone / Q000378:metabolism*; D000653:Amniotic Fluid / Q000187:drug effects* / Q000378:metabolism; D001477:Bartter Syndrome / Q000188:drug therapy* / Q000196:embryology / Q000378:metabolism; D002585:Cesarean Section; D005260:Female; D005315:Fetal Diseases / Q000188:drug therapy* / Q000196:embryology / Q000378:metabolism; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology / Q000627:therapeutic use*; D008423:Maternal Age; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D018566:Pregnancy, High-Risk; D011453:Prostaglandins / Q000378:metabolism*; D015149:Tocolytic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome
D011453:Prostaglandins; D015149:Tocolytic Agents; D000450:Aldosterone; D007213:Indomethacin